Sentara Infusion Services recalls DOBUTAMINE, (a) 1080MG IN D5W 270ML, (b) 760MG IN D5W 190ML, ionotrop, used with a home pump, Rx only, Sentara Home Infu
Recalled February 22, 2023 · FDA recall D-0290-2023 · Sentara Infusion Services
Hazard
Lack of sterility assurance · FDA Class II
Units
4
Sold at
Dispensed to Patients Nationwide.
Description
Lack of sterility assurance
Product
DOBUTAMINE, (a) 1080MG IN D5W 270ML, (b) 760MG IN D5W 190ML, ionotrop, used with a home pump, Rx only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Manufacturer(s)
Sentara Infusion Services
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →